Browse studies
Find your next paid study
14 recruiting studies matching your filters
Phase 1
A Phase 1/1b Study of VET3-TGI Administered Alone and in Combination With Atezolizumab in Patients With Advanced Solid Tumors
VET3-TGI is an oncolytic immunotherapy designed to treat advanced cancers. VET3-TGI has not been given to human patients yet, and the current study is designed…
Solid Tumor, AdultMicrosatellite Stable Colorectal CancerHead and Neck Squamous Cell Carcinoma+10 more
Estimated
~$10 – $8,750
KaliVir ImmunotherapeuticsNCT06444815
Phase 2
Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma
The purpose of this study is to determine if neoadjuvant (treatment before surgery) immunotherapy treatment based on tumor biomarkers results in better partici…
Melanoma Stage IIIMelanoma Stage IVAdvanced Melanoma+1 more
Estimated
~$10 – $6,250
H. Lee Moffitt Cancer Center and Research InstituteNCT06295159